TotalMarketCap

Legend Biotech

LEGNNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$4.387 B

$22.56 -0.94%

Close of 6 Nov 2026

As of 6 Nov 2026, Legend Biotech (LEGN) has a market capitalization of $4.39B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

369,886,369

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #56Dianthus TherapeuticsDNTH$4.69B
  2. #57ErascaERAS$4.64B
  3. #58Legend BiotechLEGN$4.39B
  4. #59Edgewise TherapeuticsEWTX$4.26B
  5. #60LiquidiaLQDA$3.98B

What if Legend Biotech were worth as much as…

Open the what-if tool →

Gold $28.2T

$145,185.38

Per share 6,437× higher

Bitcoin $1.53T

$7,855.73

Per share 348× higher

Apple $5.02T

$25,789.62

Per share 1,143× higher

Or at a round number

$10.0B$20.0B$50.0B$100.0B

Where these numbers come from

Share counts and financials for Legend Biotech are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.